{"id":"https://openalex.org/W2163293377","doi":null,"title":"Lixisenatide, a novel GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus.","display_name":"Lixisenatide, a novel GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus.","publication_year":2009,"publication_date":"2009-08-01","ids":{"openalex":"https://openalex.org/W2163293377","mag":"2163293377","pmid":"https://pubmed.ncbi.nlm.nih.gov/19629885"},"language":"en","primary_location":{"id":"pmid:19629885","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19629885","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"IDrugs : the investigational drugs journal","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051382562","display_name":"Mikkel Christensen","orcid":"https://orcid.org/0000-0002-8774-1797","observed_orcids":["https://orcid.org/0000-0002-8774-1797"]},"institutions":[{"id":"https://openalex.org/I124055696","display_name":"University of Copenhagen","ror":"https://ror.org/035b05819","country_code":"DK","type":"education","lineage":["https://openalex.org/I124055696"]},{"id":"https://openalex.org/I2800929696","display_name":"Amager Hospital","ror":"https://ror.org/02g2pz956","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2800929696","https://openalex.org/I2802567020"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Mikkel Christensen","raw_affiliation_strings":["Amager Hospital, Department of Internal Medicine, University of Copenhagen, Denmark. mikkelc@dadlnet.dk","Amager Hospital, Department of Internal Medicine, University of Copenhagen, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amager Hospital, Department of Internal Medicine, University of Copenhagen, Denmark. mikkelc@dadlnet.dk","institution_ids":["https://openalex.org/I124055696","https://openalex.org/I2800929696"]},{"raw_affiliation_string":"Amager Hospital, Department of Internal Medicine, University of Copenhagen, Denmark","institution_ids":["https://openalex.org/I124055696","https://openalex.org/I2800929696"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079352451","display_name":"Filip Krag Knop","orcid":"https://orcid.org/0000-0002-2495-5034","observed_orcids":["https://orcid.org/0000-0002-2495-5034"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Filip K Knop","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085434984","display_name":"Jens Juul Holst","orcid":"https://orcid.org/0000-0001-6853-3805","observed_orcids":["https://orcid.org/0000-0001-6853-3805"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jens J Holst","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5004120950","display_name":"Tina Vilsb\u00f8ll","orcid":"https://orcid.org/0000-0002-0456-6787","observed_orcids":["https://orcid.org/0000-0002-0456-6787"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tina Vilsboll","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.7454,"has_fulltext":false,"cited_by_count":74,"citation_normalized_percentile":{"value":0.95541556,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"12","issue":"8","first_page":"503","last_page":"13"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lixisenatide","display_name":"lixisenatide","score":1.0},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9300000071525574},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9959999918937683},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.7829999923706055},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.9039999842643738},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.6690000295639038},{"id":"https://openalex.org/keywords/beta-cell-preservation","display_name":"beta-cell preservation","score":0.671999990940094},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9240000247955322},{"id":"https://openalex.org/keywords/gastrointestinal-side-effects","display_name":"gastrointestinal adverse effects","score":0.800000011920929},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.8289999961853027},{"id":"https://openalex.org/keywords/drug-development","display_name":"drug development","score":0.4830000102519989}],"concepts":[{"id":"https://openalex.org/C2776442814","wikidata":"https://www.wikidata.org/wiki/Q6659956","display_name":"Lixisenatide","level":5,"score":0.997165322303772},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6068795919418335},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.5832337141036987},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.5329962968826294},{"id":"https://openalex.org/C2780668416","wikidata":"https://www.wikidata.org/wiki/Q202758","display_name":"Hypoglycemia","level":3,"score":0.5220629572868347},{"id":"https://openalex.org/C185280430","wikidata":"https://www.wikidata.org/wiki/Q14909910","display_name":"Glucagon-like peptide 1 receptor","level":4,"score":0.5129079818725586},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5027451515197754},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4939137101173401},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.48097267746925354},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4778572916984558},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.46723634004592896},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.38302046060562134},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.38224393129348755},{"id":"https://openalex.org/C2780533449","wikidata":"https://www.wikidata.org/wiki/Q417762","display_name":"Exenatide","level":4,"score":0.3177383542060852}],"mesh":[{"descriptor_ui":"D000067757","descriptor_name":"Glucagon-Like Peptide-1 Receptor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000067758","descriptor_name":"Glucagon-Like Peptide-2 Receptor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002352","descriptor_name":"Carrier Proteins","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D002352","descriptor_name":"Carrier Proteins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002352","descriptor_name":"Carrier Proteins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007279","descriptor_name":"Injections, Subcutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018027","descriptor_name":"Receptors, Glucagon","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true}],"locations_count":3,"locations":[{"id":"pmid:19629885","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19629885","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"IDrugs : the investigational drugs journal","raw_type":"Journal Article"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/95211680-3353-11df-8ed1-000ea68e967b","doi":null,"is_oa":false,"landing_page_url":"https://researchprofiles.ku.dk/da/publications/95211680-3353-11df-8ed1-000ea68e967b","pdf_url":null,"source":{"id":"https://openalex.org/S4306401983","display_name":"Research at the University of Copenhagen (University of Copenhagen)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I124055696","host_organization_name":"University of Copenhagen","host_organization_lineage":["https://openalex.org/I124055696"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Christensen, M, Knop, F K, Holst, J J & Vilsboll, T 2009, 'Lixisenatide, a novel GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus', IDrugs. The Investigational Drugs Journal, vol. 12, no. 8, pp. 503-13.","raw_type":"info:eu-repo/semantics/article"},{"id":"mag:2163293377","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19629885","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":16,"referenced_works":["https://openalex.org/W1598254642","https://openalex.org/W1984740259","https://openalex.org/W1986085856","https://openalex.org/W2011499650","https://openalex.org/W2013842626","https://openalex.org/W2022780776","https://openalex.org/W2054564814","https://openalex.org/W2070762414","https://openalex.org/W2071075324","https://openalex.org/W2098459806","https://openalex.org/W2108021940","https://openalex.org/W2127409471","https://openalex.org/W2143014102","https://openalex.org/W2146333376","https://openalex.org/W2164961795","https://openalex.org/W2560983962"],"related_works":["https://openalex.org/W2095774646","https://openalex.org/W2319963451","https://openalex.org/W1978569902","https://openalex.org/W2340591635","https://openalex.org/W1969897150","https://openalex.org/W2619128140","https://openalex.org/W2581477652","https://openalex.org/W2031673150","https://openalex.org/W1972187673","https://openalex.org/W2012803888"],"abstract_inverted_index":{"Lixisenatide,":[0],"under":[1],"development":[2],"by":[3,45],"sanofi-aventis,":[4],"is":[5,39],"a":[6,57,139],"novel":[7],"human":[8,54,62],"glucagon-like":[9],"peptide-1":[10],"receptor":[11],"(GLP-1R)":[12],"agonist":[13],"for":[14,155,173,183],"the":[15,158,180],"treatment":[16,181],"of":[17,28,74,142,149,157,161],"type":[18],"2":[19],"diabetes":[20],"mellitus":[21],"(T2DM;":[22],"non-insulin":[23],"dependent":[24],"diabetes).":[25],"The":[26,147],"structure":[27],"lixisenatide,":[29],"based":[30],"on":[31,163],"exendin-4(1-39)":[32],"modified":[33],"C-terminally":[34],"with":[35,56,88,124,133],"six":[36],"Lys":[37],"residues,":[38],"able":[40],"to":[41,53,118],"withstand":[42],"physiological":[43],"degradation":[44],"dipeptidyl":[46],"peptidase":[47],"IV.":[48],"In":[49,66,86,96],"vitro,":[50],"lixisenatide":[51,76,92,102,162,172],"bound":[52],"GLP-1R":[55,177],"greater":[58],"affinity":[59],"than":[60],"native":[61],"GLP-1":[63],"(7-36":[64],"amide).":[65],"various":[67],"in":[68,71,107,179],"vitro":[69],"and":[70,80,110,166],"vivo":[72],"models":[73],"T2DM,":[75,89],"improved":[77,103],"glycemic":[78,164],"measures":[79,165],"demonstrated":[81],"promising":[82],"pancreatic":[83],"beta-cell-preserving":[84],"actions.":[85],"patients":[87,117],"subcutaneously":[90],"administered":[91],"displayed":[93],"linear":[94],"pharmacokinetics.":[95],"two":[97],"phase":[98,150],"II":[99],"clinical":[100],"trials,":[101],"glucose":[104],"tolerance,":[105],"resulted":[106],"weight":[108],"loss":[109],"lowered":[111],"HbA1C,":[112],"thereby":[113],"causing":[114],"significantly":[115],"more":[116],"achieve":[119],"target":[120],"HbA1C":[121],"levels":[122],"compared":[123],"placebo.":[125],"Lixisenatide":[126],"exhibited":[127],"well-established":[128],"GLP-1-related":[129],"gastrointestinal":[130],"side":[131],"effects,":[132],"mild":[134],"nausea":[135],"occurring":[136],"most":[137],"frequently;":[138],"low":[140],"frequency":[141],"hypoglycemia":[143],"was":[144],"also":[145],"reported.":[146],"results":[148,169],"III":[151],"trials":[152],"are":[153],"awaited":[154],"confirmation":[156],"anticipated":[159],"effects":[160],"weight;":[167],"favorable":[168],"would":[170],"place":[171],"consideration":[174],"among":[175],"other":[176],"agonists":[178],"armamentarium":[182],"T2DM.":[184]},"counts_by_year":[{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":7},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}